Project ICOPE Brazil: Assessment of Intrinsic Capacity in Brazilian Older Adults
Launched by UNIVERSITY OF SAO PAULO · May 5, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The ICOPE Brazil study is a clinical trial that seeks to learn more about how older adults in Brazil age, particularly focusing on their overall health and ability to perform daily activities. The study will assess various aspects of health, including mobility (how well people can move), cognitive ability (thinking and memory), nutrition, vision, hearing, and mental health. This research is in line with recommendations from the World Health Organization to help provide better care for older adults. Participants will be monitored for three years to see how these factors change over time and to identify issues like frailty, falls, or hospitalization.
To participate in this study, individuals must be at least 60 years old and registered with a participating health care unit. They should be able to visit the study sites for assessments. However, those with severe cognitive issues, advanced illnesses, or who cannot reach the study locations will not be included. If you take part, you can expect to undergo a series of tests and questionnaires to help researchers understand how to support healthy aging in older adults. This study will contribute valuable information that could improve the lives of many seniors in Brazil.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • People aged ≥ 60 years, with no age limit;
- • Being registered (with available contact information) in the participating health care units;
- • Being available to go in person to the data collection sites for the assessments.
- • Exclusion criteria
- • Inability to access the data collection site;
- • Severe neurologic and/or cognitive impairments that preclude interaction with the evaluators to complete the proposed tests and data collections;
- * Advanced serious illness or under palliative care:
- • Clinical Frailty Scale (CFS)20 score of 8 (severely frail) or 9 (terminally ill).
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Eduardo Ferriolli, MD, MSc, PhD
Study Chair
University of Sao Paulo
Renato Bandeira de Mello, MD, MPH, PhD
Study Director
Federal University of Rio Grande do Sul
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported